Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition

Plain-language summary

This study examined the effect of sequential informational messages sent through electronic health records to increase genetic testing for susceptibility to breast cancer and ovarian cancer. It enrolled people with certain personal or family cancer histories who had not previously received genetic counseling or testing. It was a trial without an assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

Abramson Cancer Center at Penn Medicine

Intervention

Sequential EHR Communications

Start date

5/1/2023

Estimated completion

12/31/2025

Countries

United States

Related genes

Locations

• Philadelphia, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

1. Patients with serous ovarian cancer diagnosed more than two years prior to study contact
2. Patients with breast cancer diagnosed at \<50 years of age more than two years prior to study contact
3. Patients with triple negative breast cancer diagnosed more than two years prior to study contact
4. Unaffected individuals reporting a family history of ovarian cancer
5. Unaffected individuals reporting a family history of male breast cancer
6. Unaffected individuals reporting a family history of breast cancer \<50 years

Exclusion Criteria:

1\. Patients who have previously received genetic counseling and/or testing